We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Extraction Kits Enable Molecular Confirmation of Genetic Disorders

By LabMedica International staff writers
Posted on 21 Oct 2013
Blood DNA 200 extraction assays provide a purified DNA preparation, reduce inhibition in downstream analysis, and ensure accurate and sensitive confirmation of Factor V Leiden thrombophilia, cystic fibrosis, and other genetic disorders.

The molecular testing for genetic mutations provides valuable confirmation of diagnosis and enables carriers of the mutated genes to be identified. More...
The performance of these molecular tests can be affected by a number of factors, including the quality of the DNA preparation.

The DiaSorin (Saluggia, Italy) blood DNA 200 extraction kits utilize magnetic bead technology to ensure high yields of purified genomic DNA from just 200 µL of whole blood. Used together with the DiaSorin Arrow instrument, it automates the extraction of genomic DNA, which reduces technician hands-on time and increases sample throughput in genetic laboratories. The blood DNA 200 cartridges are loaded onto the Arrow instrument for up to 12 patient samples and, in 35 minutes, a high yield, high purity genomic DNA preparation is ready for use in a number of downstream applications.

DiaSorin nucleic acid extraction kits are also available for a number of applications: the extraction of RNA or DNA from a variety of sample matrices; the extraction of DNA from stool and larger blood samples; BUGS’n BEADS for the extraction of nucleic acid from a variety of pathogens; and cell separation.

Related Links:
DiaSorin


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.